AEM vs GFI

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

GFI exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.37. While the current price of $44.99 is significantly above the defensive Graham Number ($20.44), it remains well below the growth-based intrinsic value of $116.23. The company is delivering massive profitability with an ROE of 51.93% and explosive YoY earnings growth of 196.10%. Despite a bearish technical trend and lukewarm insider sentiment, the fundamental value proposition and analyst targets suggest significant upside.